Health & Biotech
Stories by Nadine McGrath
News
After Neuren’s success, which other ASX health stocks are knocking on the US FDA door?
News
Top 10 at 10: Which gold explorer is about to go back in time to the Victorian Goldfields?
News
Top 10 at 10: Which gold junior is up 120pc after signing a US$300m funding facility?
News
What’s your spending? 50% of Australians don’t know how much they spent in past month
Experts
Prime Asset Value’s three tips to manage volatility in the ASX small cap market
News
Top 10 at 10: Which energy company is rising after a Magnolia co-operation deal?
Experts
MoneyTalks: Why real estate portal Domain is among Prime Value’s top three ASX picks
Health & Biotech
ScoPo’s Powerplays: ASX health stocks drop as Neuren surges 60% on US FDA approval
Experts
Pearler gives kids ‘headstart’ with new investing app where volatility doesn’t perturb investors
Experts
LIC vs ETF: Six differences between them and why one has become more popular
News